2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6 Linagliptin Maʻemaʻe Kūwaena ≥99.0% (HPLC)
Hāʻawi ka mea hana i ka Linagliptin a me nā mea pili e pili ana:
Linagliptin CAS 668270-12-0
Linagliptin Mākua Nucleus Intermediate CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Inoa Kimia | 2-(Chloromethyl)-4-Methylquinazoline |
Nā huaʻōlelo like | ʻO Linagliptin Intermediate A |
Helu CAS | 109113-72-6 |
Helu CAT | RF-PI498 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C10H9ClN2 |
Kaumaha Molecular | 192.64 |
ʻO ka mānoanoa | 1.251 |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | Melemele ʻeleʻele i ka pauda ʻeleʻele |
ʻIkepili A | Pono ka hāpana IR spectrum me ka spectrum maʻamau |
ʻIkepili B | Pono ka manawa paʻa o ka piko kumu o ka hāpana e kūlike me ka maʻamau |
Ka hoʻoheheʻe | Hiki ke hoʻoheheʻe ʻia i ka Methylene Chloride;ʻAʻole hiki ke hoʻonā i ka wai |
Maʻemaʻe / Kaʻina Hanana | ≥99.0% (HPLC) |
Lae hehee | 60.0 a 65.0 ℃ |
Wai (KF) | ≤0.50% |
Koena ma ka Ignition | ≤0.50% |
Na mea pili | |
Hoʻokahi haumia | ≤0.30% |
Huina paumaele | ≤1.0% |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Waena no Linagliptin (CAS: 668270-12-0) |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.
Hoʻohana ʻia ʻo 2-(Chloromethyl) -4-Methylquinazoline (CAS: 109113-72-6) ma ke ʻano he waena no ka hoʻomākaukau ʻana o Linagliptin (CAS: 668270-12-0), a me kāna mau mea haumia.ʻO Linagliptin, i kūʻai ʻia ma lalo o ka inoa inoa ʻo Tradjenta ma waena o nā mea ʻē aʻe, he lāʻau lapaʻau i hoʻohana ʻia no ka mālama ʻana i ka maʻi diabetes type 2. ʻAʻole i makemake nui ʻia ma mua o ka metformin a me ka sulfonylureas ma ke ʻano he lapaʻau mua.Hoʻohana pū ʻia me ka hoʻoikaika kino a me ka ʻai.ʻAʻole ʻōlelo ʻia i ka maʻi diabetes type 1.Hoʻohana ia ma ka hoʻonui ʻana i ka hana ʻana o ka insulin a hoʻemi i ka hana ʻana o ka glucagon e ka pancreas.Ua ʻae ʻia ʻo Linagliptin no ka hoʻohana ʻana i ka lāʻau lapaʻau ma ʻAmelika Hui Pū ʻIa i ka makahiki 2011. ʻO Linagliptin kahi mea ikaika loa, koho i ka dipeptidyl peptidase-4 (DPP-4) inhibitor me IC50 o 1 nM.